The molecular diagnostics market is growing due to rising demand for early detection, precision medicine, and infectious disease testing. Advanced technologies like PCR and NGS enhance accuracy and speed. North America leads, while Asia Pacific expands rapidly. Reagents and kits dominate, with strong competition driven by innovation, partnerships, and increasing global healthcare investments.
According to a research study published by Knowledge Sourcing Intelligence (KSI), the molecular diagnostics technologies market will expand from USD 21.9 billion in 2026 to USD 33.5 billion in 2031 at a CAGR of 8.9% during the forecast period.
The molecular diagnostics technologies market will experience consistent expansion because there is a growing requirement for diagnostic solutions that provide both speed and precision, and because genomic technology continues to progress.
Access sample report or view details: https://www.knowledge-sourcing.com/report/molecular-diagnostics-technologies-market
Key Market Insight & Emerging Trends:
The healthcare sector is expanding its molecular diagnostic technologies market because of the rising demand for early disease detection, precision medicine, and personalized treatment methods. The market experiences growth because of increasing infectious disease and cancer cases, together with rising public awareness about genetic testing.
Next-generation sequencing (NGS) and real-time PCR technologies enable more accurate diagnoses, which require less time for results. The healthcare industry benefits from two trends, which are the rising use of point-of-care molecular diagnostics and laboratory automation systems.
The market growth accelerates because government programs support genomic research, while molecular diagnostics become integrated into standard clinical operations. The healthcare systems of emerging Asian economies experience rapid development because of their upgraded medical facilities and higher health expenditure.
North America maintained its market leadership during 2025 because of its advanced laboratory systems and the presence of major industry players.
The market by product type shows reagents and kits as the leading product category because these items are used by doctors for their diagnostic tests.
PCR technology remains the leading market solution because of its extensive use and ability to identify pathogens with high accuracy.
The application of infectious diseases accounts for a major market share because of the requirement for fast disease identification and effective epidemic response.
The market for molecular diagnostic technologies operates with high competition because top companies emphasize both product innovation and the development of new products, and the formation of business partnerships.
Product Insights: Reagents & Kits Segment Leading Demand
The reagents and kits segment held the highest market share during 2025 because diagnostic tests require their products to be used continuously. The rising demand for testing infectious diseases and genetic disorders leads to an ongoing need for superior reagents and assay kits.
Technology Insights: PCR as the Major Technology
The market continues to depend on Polymerase Chain Reaction (PCR) technology because it delivers accurate results with high sensitivity and produces results at a fast rate. The technology acts as the main solution for various fields that include detecting infectious diseases and conducting genetic studies.
Application Insights: Infectious Diseases Driving Market Growth
The molecular diagnostics technologies market enables swift pathogen detection, which helps medical professionals to handle disease outbreaks effectively. The increasing global outbreaks of new infectious diseases and the need for fast diagnostic tests will create new business opportunities.
Regional Highlights: North America Dominance with Rapid Asia Pacific Growth
North America preserved its top position in 2025 because its healthcare systems function effectively, its research and development funds grow, and its medical facilities use modern diagnostic tools. The Asia Pacific region will experience rapid development during the forecast period because healthcare access expands, the population grows, and governments increase their disease surveillance efforts.
Competitive Landscape
As a part of the report, the major players operating in the molecular diagnostics technologies market have been covered, such as Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Qiagen, Bio-Rad Laboratories, Hologic, Agilent Technologies, Illumina, and Siemens Healthineers. The major companies in this market strengthen their position through product development, technological progress, and expansion into new markets, while smaller companies and local businesses concentrate on affordable diagnostic products in specific markets.
Market Segmentation
The report segments the molecular diagnostics technologies market as follows:
By Product Type
Instruments
Reagents & Kits
Software & Services
By Technology
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
In Situ Hybridization (ISH)
Microarrays
Isothermal Nucleic Acid Amplification
By Application
Infectious Diseases
Oncology
Genetic Testing
Blood Screening
Transplant Diagnostics
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others
Companies Profiled:
Roche Diagnostics
Thermo Fisher Scientific
Abbott Laboratories
Danaher Corporation
Qiagen
Bio-Rad Laboratories
Hologic
Agilent Technologies
Illumina
Siemens Healthineers
Explore More Reports:
Have questions?
More Press Releases
Modular AI Data Center Infrastructure Market to Reach USD 8.71 Billion by 2032, Driven by Rapid Deployment of Prefabricated AI Data Centers
The global modular AI data center infrastructure market is expanding as demand for high-density computing and faster AI infrastructure deployment increases. Prefabricated power modules, integrated cooling systems, and turnkey AI factory solutions are gaining traction among hyperscale operators and neocloud providers seeking scalable, energy-efficient infrastructure to support increasingly complex AI workloads.
Autonomous Vehicle Interior Market to Reach USD 26.53 Billion by 2031, Driven by AI-Powered Smart Cockpits and Human-Machine Interfaces
The global autonomous vehicle interior market is expanding as AI-powered smart cockpits, advanced human-machine interfaces, and occupant monitoring technologies transform in-vehicle experiences. Growing adoption of software-defined vehicle architectures, connected infotainment, and personalized cabin systems is creating opportunities for automotive suppliers as higher-level vehicle automation advances across global markets.
Data Center Silicon Photonics Market to Reach USD 23.1 Billion by 2032, Driven by AI Infrastructure and Co-Packaged Optics Adoption
The global data center silicon photonics market is expanding as AI infrastructure, hyperscale computing, and high-bandwidth networking increase demand for advanced optical connectivity. Innovations in co-packaged optics, photonic integrated circuits, and energy-efficient interconnects are creating growth opportunities, while manufacturing scalability, thermal management, and integration costs remain important industry considerations.
